Novartis already bought into optogenetic gene therapy technology last year, but the Swiss Pharma wants more. Enter Arctos Medical, which will now join Novartis with its gene therapy program for vision ...

A new type of gene therapy that rewires nerve cells in the eye has given a blind man some limited vision. The 58-year-old man has a genetic disease called retinitis pigmentosa, which causes ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced retinitis pigmentosa who received intravitreal optogenetics gene therapy in a phase 1/2a ...

What the scientists had was a lab version of The Dog That Didn’t Bark — or, if Sherlock Holmes were chronicling the experiment, The Mice That Didn’t Freeze. One at a time, the 20 mice went into a ...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies ...

A new paper in Oxford Open Neuroscience, published by Oxford University Press, indicates that optogenetics, suggested as a promising treatment for many psychological and neurological conditions, may ...

Effective treatments for incontinence are urgently needed. Now, a multi-institutional team of researchers has developed a wireless system that can measure bladder function in freely moving rats over ...

Using a technique called optogenetics, researchers added light-sensitive proteins to the man’s retina, giving him a blurry view of objects. By Carl Zimmer A team of scientists announced Monday that ...

Until now, genetically modifying cells with light has been used in research to help understand the brain. Now it’s being trialled as a blindness treatment LET there be light. For the first time, a ...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Paris: SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative ...